January 14, 2026

On-Demand Event Recording: Smarter & Faster Candidate Identification with AI-Driven Imaging

Event Length: 1h including Q&A

Watch our on-demand program recording where globally recognized experts share actionable insights on leveraging the latest technology with AI to streamline Candidate Identification and overcome long-standing clinical trial recruitment challenges.

Key Highlights

  • Discover why traditional enrollment methods fall short and how AI streamlines candidate identification.
  • Learn how Imaging & EHR data unite to find the right candidates for complex trials.
  • Explore AI-driven approaches to improve enrolment efficiency, speed up recruitment, and ease patient burden.
  • See how data-driven insights improve site selection, protocol design, and trial efficiency for clinical studies.

Meet Our Speakers

David Eichenbaum, MD I Retina Vitreous Associates
of Florida

Dr. Eichenbaum is a retina specialist, Partner and Director of Research at RVAF and Collaborative Associate Professor at the Morsani College of Medicine at the University of South Florida, with a distinguished career in the diagnosis and treatment of vitreoretinal diseases. He completed his ophthalmology residency at the University of South Florida, and a surgical retina fellowship at Tufts New England Eye Center and Ophthalmic Consultants of Boston. He has served as Principal Investigator in over 100 retina clinical trials and has published in several professional journals and textbook chapters.

Arshad M. Khanani, MD, MA, FASRS I Sierra Eye Associates, University of Nevada, Reno School of Medicine

Dr. Khanani is Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates, and Clinical Professor at the University of Nevada, Reno. He has led more than 120 clinical trials, including serving as chair of the Phase 3 GATHER2 steering committee that supported IZERVAY’s approval for geographic atrophy. Widely published with over 150 scientific papers, Dr. Khanani is a frequent international speaker, founder of the Clinical Trials at the Summit meeting, and an active member of leading retinal societies. His contributions to advancing treatments for retinal diseases have earned him numerous honors, including the ASRS Presidents’ Young Investigator Award and the ASRS Presidential Award.

Omer Trivizki, MD, MBA I Bascom Palmer Eye Institute
Tel Aviv Medical Center

Dr. Omer Trivizki, MD, MBA, is a renowned retina specialist at Tel Aviv Medical Center, serving as Vice Chair of Ophthalmology and leads the Digital Initiative. He also holds a Clinical Senior Lecturer position at Tel Aviv University and is a Research Associate at the Bascom Palmer Eye Institute. He is dedicated to advancing the integration of AI, focusing on developing innovative imaging-based analysis workflows to improve efficiency of trials and patient recruitment in retinal studies.